Ignite Creation Date:
2025-12-26 @ 10:36 AM
Ignite Modification Date:
2025-12-29 @ 2:09 PM
Study NCT ID:
NCT00444028
Status:
COMPLETED
Last Update Posted:
2018-11-20
First Post:
2007-03-05
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Staccato Loxapine Single Dose PK
Sponsor:
Alexza Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-09
Start Date Type:
None
Primary Completion Date:
2005-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2005-11
Completion Date Type:
ACTUAL
First Submit Date:
2007-03-05
First Submit QC Date:
None
Study First Post Date:
2007-03-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-01-30
Results First Submit QC Date:
None
Results First Post Date:
2018-11-20
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-11-17
Last Update Post Date:
2018-11-20
Last Update Post Date Type:
ACTUAL